Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | LPAR1 | Q92633 | 10/20 | 0.47 |
| ▸ | LTB4R2 | Q9NPC1 | 4/20 | 0.45 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.45 |
| ▸ | LTB4R | Q15722 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5400923 | 0.92 | PPARG (0.48) | FFAR1FFAR4LPAR1LTB4R2LPAR5 | |
| SCHEMBL5400875 | 0.91 | LTB4R2 (0.45) | FFAR1FFAR4LPAR1LTB4R2LPAR5 | |
| SCHEMBL5414300 | 0.91 | LTB4R2 (0.53) | FFAR1FFAR4LPAR1LTB4R2LTB4R | |
| SCHEMBL5395527 | 0.91 | LPAR1 (0.43) | LPAR1LTB4R2LPAR5LTB4RMEN1 | |
| SCHEMBL5418587 | 0.90 | LPAR1 (0.58) | LPAR1LPAR5MEN1KMT2A | |
| SCHEMBL5402294 | 0.89 | LTB4R (0.49) | FFAR1FFAR4LTB4R2LTB4RCYP1A2 | |
| SCHEMBL5395687 | 0.89 | LPAR1 (0.50) | LPAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL5406272 | 0.87 | LPAR1 (0.49) | LPAR1LTB4R2MEN1KMT2A | |
| SCHEMBL5407075 | 0.86 | LPAR1 (0.45) | FFAR1FFAR4LPAR1LTB4R2L3MBTL1 | |
| SCHEMBL5398686 | 0.86 | LPAR1 (0.49) | LPAR1LTB4R2LTB4RL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7285680-B2 | β-alanine derivatives and the use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-10-23 | — | — | US | disclosed |
| US-20050256160-A1 | Beta-alanine derivatives and the use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-11-17 | — | — | US | disclosed |
| EP-1533294-A1 | BETA-ALANINE DERIVATIVE AND USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256160-A1 | Beta-alanine derivatives and the use thereof | TGFB1, PML, APOB | FFAR1 65/4885FFAR4 187/4885LPAR1 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.